Your browser doesn't support javascript.
loading
Biallelic AOPEP Loss-of-Function Variants Cause Progressive Dystonia with Prominent Limb Involvement.
Zech, Michael; Kumar, Kishore R; Reining, Sophie; Reunert, Janine; Tchan, Michel; Riley, Lisa G; Drew, Alexander P; Adam, Robert J; Berutti, Riccardo; Biskup, Saskia; Derive, Nicolas; Bakhtiari, Somayeh; Jin, Sheng Chih; Kruer, Michael C; Bardakjian, Tanya; Gonzalez-Alegre, Pedro; Keller Sarmiento, Ignacio J; Mencacci, Niccolo E; Lubbe, Steven J; Kurian, Manju A; Clot, Fabienne; Méneret, Aurélie; de Sainte Agathe, Jean-Madeleine; Fung, Victor S C; Vidailhet, Marie; Baumann, Matthias; Marquardt, Thorsten; Winkelmann, Juliane; Boesch, Sylvia.
Afiliação
  • Zech M; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
  • Kumar KR; Technical University of Munich, Munich, Germany.
  • Reining S; School of Medicine, Technical University of Munich, Institute of Human Genetics, Munich, Germany.
  • Reunert J; Molecular Medicine Laboratory and Neurology Department, Concord Clinical School, Concord Repatriation General Hospital, The University of Sydney, Sydney, New South Wales, Australia.
  • Tchan M; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Riley LG; Department of General Paediatrics, University of Münster, Münster, Germany.
  • Drew AP; Department of General Paediatrics, University of Münster, Münster, Germany.
  • Adam RJ; Department of Genetic Medicine, Westmead Hospital, Westmead, New South Wales, Australia.
  • Berutti R; Sydney Medical School, University of Sydney, Camperdown, New South Wales, Australia.
  • Biskup S; Discipline of Child & Adolescent Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Derive N; Rare Diseases Functional Genomics, Kids Research, The Children's Hospital at Westmead and The Children's Medical Research Institute, Sydney, New South Wales, Australia.
  • Bakhtiari S; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Jin SC; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Kruer MC; Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Bardakjian T; Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
  • Gonzalez-Alegre P; Technical University of Munich, Munich, Germany.
  • Keller Sarmiento IJ; School of Medicine, Technical University of Munich, Institute of Human Genetics, Munich, Germany.
  • Mencacci NE; CeGaT GmbH und Praxis für Humangenetik Tübingen, Tübingen, Germany.
  • Lubbe SJ; Laboratoire de Biologie Médicale Multi-Sites SeqOIA, Paris, France.
  • Kurian MA; Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
  • Clot F; Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
  • Méneret A; Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • de Sainte Agathe JM; Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
  • Fung VSC; Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
  • Vidailhet M; Department of Neurology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Baumann M; Department of Neurology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Marquardt T; Ken and Ruth Davee Department of Neurology, and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
  • Winkelmann J; Ken and Ruth Davee Department of Neurology, and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
  • Boesch S; Ken and Ruth Davee Department of Neurology, and Simpson Querrey Center for Neurogenetics, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Mov Disord ; 37(1): 137-147, 2022 01.
Article em En | MEDLINE | ID: mdl-34596301
BACKGROUND: Monogenic causes of isolated dystonia are heterogeneous. Assembling cohorts of affected individuals sufficiently large to establish new gene-disease relationships can be challenging. OBJECTIVE: We sought to expand the catalogue of monogenic etiologies for isolated dystonia. METHODS: After the discovery of a candidate variant in a multicenter exome-sequenced cohort of affected individuals with dystonia, we queried online platforms and genomic data repositories worldwide to identify subjects with matching genotypic profiles. RESULTS: Seven different biallelic loss-of-function variants in AOPEP were detected in five probands from four unrelated families with strongly overlapping phenotypes. In one proband, we observed a homozygous nonsense variant (c.1477C>T [p.Arg493*]). A second proband harbored compound heterozygous nonsense variants (c.763C>T [p.Arg255*]; c.777G>A [p.Trp259*]), whereas a third proband possessed a frameshift variant (c.696_697delAG [p.Ala234Serfs*5]) in trans with a splice-disrupting alteration (c.2041-1G>A). Two probands (siblings) from a fourth family shared compound heterozygous frameshift alleles (c.1215delT [p.Val406Cysfs*14]; c.1744delA [p.Met582Cysfs*6]). All variants were rare and expected to result in truncated proteins devoid of functionally important amino acid sequence. AOPEP, widely expressed in developing and adult human brain, encodes a zinc-dependent aminopeptidase, a member of a class of proteolytic enzymes implicated in synaptogenesis and neural maintenance. The probands presented with disabling progressive dystonia predominantly affecting upper and lower extremities, with variable involvement of craniocervical muscles. Dystonia was unaccompanied by any additional symptoms in three families, whereas the fourth family presented co-occurring late-onset parkinsonism. CONCLUSIONS: Our findings suggest a likely causative role of predicted inactivating biallelic AOPEP variants in cases of autosomal recessive dystonia. Additional studies are warranted to understand the pathophysiology associated with loss-of-function variation in AOPEP. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distúrbios Distônicos / Distonia / Mutação com Perda de Função / Aminopeptidases Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Distúrbios Distônicos / Distonia / Mutação com Perda de Função / Aminopeptidases Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article